tiprankstipranks
Trending News
More News >
Xtant Medical Holdings (XTNT)
:XTNT
US Market
Advertisement

Xtant Medical Holdings (XTNT) Earnings Dates, Call Summary & Reports

Compare
287 Followers

Earnings Data

Report Date
Mar 05, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
>-0.01
Last Year’s EPS
-0.02
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 10, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call presents a positive outlook with strong revenue growth, improved margins, and successful new product launches. However, there are some challenges in hardware revenue and slower than expected growth in the biologics product family. The pending asset sale is expected to further strengthen the company's financial position.
Company Guidance
During Xtant Medical Holdings, Inc.'s third quarter 2025 financial results call, several key metrics and strategic updates were provided. The company reported a 19% increase in revenue year-over-year, reaching $33.3 million, with licensing revenue contributing $5.5 million. The gross margin improved to 66.1% from 58.4% in the previous year, attributed to favorable sales mix and scale. The company achieved a net income of $1.3 million, reversing a net loss of $5 million in the same period of 2024. Adjusted EBITDA was reported at $4.5 million, marking a significant improvement from the previous year's loss. Additionally, the company is anticipating the completion of a significant asset sale, expected to yield $19.2 million in proceeds, which will be used to reduce debt and improve liquidity. Revenue guidance for the full year 2025 remains between $131 million and $135 million, reflecting an 11% to 15% growth over 2024. The company also highlighted strategic initiatives, including investments in R&D and expansion of their commercial team, aimed at driving growth in their core biologics business.
Strong Revenue Growth
The company reported a 19% revenue growth over 2024, reaching $33.3 million in the third quarter of 2025.
Increased Gross Margin
Gross margin improved to 66.1% from 58.4% in the same period in 2024, attributed to favorable sales mix and greater scale.
Positive Net Income
The company achieved a net income of $1.3 million, or 1¢ per share, compared to a net loss of $5 million in the comparable 2024 period.
Successful Product Launches
The launch of new products like Collagen X and growth in core biologics product family, despite being below long-term expectations, contribute to future growth potential.
Pending Asset Sale
The sale of non-core assets to Companion Spine is expected to provide $19.2 million, strengthening the company's financial position and focusing on core business.

Xtant Medical Holdings (XTNT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

XTNT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 05, 2026
2025 (Q4)
>-0.01 / -
-0.02
Nov 10, 2025
2025 (Q3)
>-0.01 / 0.01
-0.04125.00% (+0.05)
Aug 12, 2025
2025 (Q2)
-0.01 / -0.09
-0.03-213.33% (-0.06)
May 12, 2025
2025 (Q1)
>-0.01 / 0.28
-0.031030.00% (+0.31)
Mar 06, 2025
2024 (Q4)
-0.01 / -0.02
-0.0333.33% (<+0.01)
Nov 12, 2024
2024 (Q3)
-0.03 / -0.04
0.07-157.14% (-0.11)
Aug 08, 2024
2024 (Q2)
-0.02 / -0.03
-0.02-50.00% (>-0.01)
May 15, 2024
2024 (Q1)
- / -
-0.02
Apr 01, 2024
2023 (Q4)
-0.02 / -0.03
-0.02-50.00% (>-0.01)
Nov 09, 2023
2023 (Q3)
-0.01 / 0.07
-0.025380.00% (+0.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

XTNT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 10, 2025
$0.76$0.76-0.66%
Aug 12, 2025
$0.59$0.67+14.14%
May 12, 2025
$0.52$0.60+14.62%
Mar 06, 2025
$0.48$0.46-4.36%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Xtant Medical Holdings (XTNT) report earnings?
Xtant Medical Holdings (XTNT) is schdueled to report earning on Mar 05, 2026, After Close (Confirmed).
    What is Xtant Medical Holdings (XTNT) earnings time?
    Xtant Medical Holdings (XTNT) earnings time is at Mar 05, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is XTNT EPS forecast?
          XTNT EPS forecast for the fiscal quarter 2025 (Q4) is >-0.01.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis